Session Details

F003 Psychocutaneous Disease: Treating the Difficult Patient

Fri, Mar 8, 9:00 AM - 11:00 AM
Room 32B
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Common psychocutaneous diseases include delusional infestation (delusions of parasitosis), skin picking disorder and other body-focused and repetitive behaviors, and body dysmorphic disorder (BDD). Affected individuals routinely refuse a psychiatric referral, so the burden of care often falls exclusively upon the dermatologist. The session will focus on managing such conditions in the complex patient, including using effective drugs and psychotherapies. Speakers will also discuss diagnostic tools for BDD and Zoom dysmorphia, skin conditions with secondary mental illness, and personality disorders in the dermatology setting; lastly, how to handle angry-frustrated and aggressive patients and implement stress reduction interventions.

LEARNING OBJECTIVES

1.

Describe common psychocutaneous diseases and recognize the associated psychiatric/psychosocial comorbidities.

2.

Discuss skin diseases associated with mental illness and the approach to the patient with a personality disorder in the dermatology setting.

3.

Develop appropriate management plans for the difficult patient with a psychocutaneous disease, including effective drugs and psychotherapies. Discuss how to handle angry-frustrated and aggressive patients and implement stress reduction interventions.

SCHEDULE

5:00 PM

A rose by any other name: the approach to the patient with delusional infestation

Jenny Eileen Murase, MD, FAAD

5:15 PM

Skin picking disorder and other body-focused repetitive behaviors: how to help your patients

Katlein Franca, PhD, MD, MSc

5:30 PM

Body dysmorphic disorder and Zoom dysmorphia: red flags and diagnostic tools

George Kroumpouzos, MD, PhD, FAAD

5:45 PM

Psychopharmacology in dermatology

John Y. M. Koo, MD, FAAD

6:00 PM

Q&A

George Kroumpouzos, MD, PhD, FAAD, Katlein Franca, PhD, MD, MSc, John Y. M. Koo, MD, FAAD, Jenny Eileen Murase, MD, FAAD

6:10 PM

Skin conditions with secondary mental illness

Nicholas Brownstone, MD

6:25 PM

Personality disorders and the difficult dermatology patient

Mio Nakamura, MD, MS, FAAD

6:40 PM

How to turn patient conflict into partnership

Jason S. Reichenberg, MD, FAAD

6:55 PM

Q&A

Nicholas Brownstone, MD, Mio Nakamura, MD, MS, FAAD, Jason S. Reichenberg, MD, FAAD

SPEAKERS

Nicholas Brownstone, MD

Nicholas Brownstone, MD

Katlein Franca, PhD, MD, MSc

Katlein Franca, PhD, MD, MSc

John Y. M. Koo, MD, FAAD

John Y. M. Koo, MD, FAAD

George Kroumpouzos, MD, PhD, FAAD

George Kroumpouzos, MD, PhD, FAAD

Jenny Eileen Murase, MD, FAAD

Jenny Eileen Murase, MD, FAAD

Mio Nakamura, MD, MS, FAAD

Mio Nakamura, MD, MS, FAAD

Jason S. Reichenberg, MD, FAAD

Jason S. Reichenberg, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Nicholas Brownstone, MD

No financial relationships exist with ineligible companies.

Katlein Franca, PhD, MD, MSc

Health.com – Advisory Board(Honoraria); Springer Publishing – Other(Other Financial Benefit); Verywell Health – Advisory Board(Fees); Wiley-Blackwell – Other(Other Financial Benefit);

John Y. M. Koo, MD, FAAD

AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Advisory Board(Honoraria), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Speaker(Honoraria); Dermavant Sciences, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Eli Lilly – Advisory Board(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Leo Pharma Inc. – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Speaker(Honoraria);

George Kroumpouzos, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Jenny Eileen Murase, MD, FAAD

AbbVie – Consultant(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); UCB – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); UpToDate – Consultant(Honoraria);

Mio Nakamura, MD, MS, FAAD

Amgen – Investigator(Salary); argenx – Advisory Board(Honoraria), Investigator(Salary); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Salary); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Salary); Pfizer Inc. – Investigator(Salary); Regeneron – Investigator(Grants/Research Funding), Investigator(Salary); Sol-Gel Technologies – Investigator(Salary);

Jason S. Reichenberg, MD, FAAD

No financial relationships exist with ineligible companies.